Covid-19 Vaccine Market, Global Outlook and Forecast 2022-2028

January 2022 | 118 pages | ID: C89B6323D130EN
Market Monitor Global

Abstracts

The negative electrode of lithium-ion battery is made by mixing the negative active material carbon material or non-carbon material, binders and additives to make a paste glue, evenly smearing on both sides of the copper foil, and then drying and rolling.

This report contains market size and forecasts of Anode Material For Lithium Battery in global, including the following market information:

Global Anode Material For Lithium Battery Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Anode Material For Lithium Battery Market Sales, 2017-2022, 2023-2028, (Kiloton)

Global top five Anode Material For Lithium Battery companies in 2021 (%)

The global Anode Material For Lithium Battery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Artificial Graphite Anode Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anode Material For Lithium Battery include Hitachi Chemical, JFE Chemical, BTR, Shinzoom and Fangda Carbon New Material Co Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anode Material For Lithium Battery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anode Material For Lithium Battery Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Anode Material For Lithium Battery Market Segment Percentages, by Type, 2021 (%)

• Artificial Graphite Anode
• Natural Graphite Anode
• Others

Global Anode Material For Lithium Battery Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Anode Material For Lithium Battery Market Segment Percentages, by Application, 2021 (%)

• New Energy Vehicles
• Aerospace
• Biomedical Science
• Others

Global Anode Material For Lithium Battery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Anode Material For Lithium Battery Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anode Material For Lithium Battery revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Anode Material For Lithium Battery revenues share in global market, 2021 (%)

Key companies Anode Material For Lithium Battery sales in global market, 2017-2022 (Estimated), (Kiloton)

Key companies Anode Material For Lithium Battery sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Hitachi Chemical
• JFE Chemical
• BTR
• Shinzoom
• Fangda Carbon New Material Co Ltd

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Covid-19 Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Covid-19 Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COVID-19 VACCINE OVERALL MARKET SIZE

2.1 Global Covid-19 Vaccine Market Size: 2021 VS 2028
2.2 Global Covid-19 Vaccine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Covid-19 Vaccine Players in Global Market
3.2 Top Global Covid-19 Vaccine Companies Ranked by Revenue
3.3 Global Covid-19 Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Covid-19 Vaccine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Covid-19 Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Covid-19 Vaccine Players in Global Market
  3.6.1 List of Global Tier 1 Covid-19 Vaccine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Covid-19 Vaccine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Covid-19 Vaccine Market Size Markets, 2021 & 2028
  4.1.2 DNA
  4.1.3 Live Attenuated Virus
  4.1.4 NonReplicating Viral Vecto
  4.1.5 Protein Subunit
  4.1.6 RNA
4.2 By Type - Global Covid-19 Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Covid-19 Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Covid-19 Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Covid-19 Vaccine Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Covid-19 Vaccine Market Size, 2021 & 2028
  5.1.2 Treatment
  5.1.3 Prevention
5.2 By Application - Global Covid-19 Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Covid-19 Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Covid-19 Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Covid-19 Vaccine Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Covid-19 Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Covid-19 Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Covid-19 Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Covid-19 Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Covid-19 Vaccine Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Covid-19 Vaccine Revenue, 2017-2028
  6.3.2 US Covid-19 Vaccine Market Size, 2017-2028
  6.3.3 Canada Covid-19 Vaccine Market Size, 2017-2028
  6.3.4 Mexico Covid-19 Vaccine Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Covid-19 Vaccine Revenue, 2017-2028
  6.4.2 Germany Covid-19 Vaccine Market Size, 2017-2028
  6.4.3 France Covid-19 Vaccine Market Size, 2017-2028
  6.4.4 U.K. Covid-19 Vaccine Market Size, 2017-2028
  6.4.5 Italy Covid-19 Vaccine Market Size, 2017-2028
  6.4.6 Russia Covid-19 Vaccine Market Size, 2017-2028
  6.4.7 Nordic Countries Covid-19 Vaccine Market Size, 2017-2028
  6.4.8 Benelux Covid-19 Vaccine Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Covid-19 Vaccine Revenue, 2017-2028
  6.5.2 China Covid-19 Vaccine Market Size, 2017-2028
  6.5.3 Japan Covid-19 Vaccine Market Size, 2017-2028
  6.5.4 South Korea Covid-19 Vaccine Market Size, 2017-2028
  6.5.5 Southeast Asia Covid-19 Vaccine Market Size, 2017-2028
  6.5.6 India Covid-19 Vaccine Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Covid-19 Vaccine Revenue, 2017-2028
  6.6.2 Brazil Covid-19 Vaccine Market Size, 2017-2028
  6.6.3 Argentina Covid-19 Vaccine Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Covid-19 Vaccine Revenue, 2017-2028
  6.7.2 Turkey Covid-19 Vaccine Market Size, 2017-2028
  6.7.3 Israel Covid-19 Vaccine Market Size, 2017-2028
  6.7.4 Saudi Arabia Covid-19 Vaccine Market Size, 2017-2028
  6.7.5 UAE Covid-19 Vaccine Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Inovio Pharmaceuticals
  7.1.1 Inovio Pharmaceuticals Corporate Summary
  7.1.2 Inovio Pharmaceuticals Business Overview
  7.1.3 Inovio Pharmaceuticals Covid-19 Vaccine Major Product Offerings
  7.1.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.1.5 Inovio Pharmaceuticals Key News
7.2 Takis Biotech (Evvivax)
  7.2.1 Takis Biotech (Evvivax) Corporate Summary
  7.2.2 Takis Biotech (Evvivax) Business Overview
  7.2.3 Takis Biotech (Evvivax) Covid-19 Vaccine Major Product Offerings
  7.2.4 Takis Biotech (Evvivax) Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.2.5 Takis Biotech (Evvivax) Key News
7.3 Zydus Cadila
  7.3.1 Zydus Cadila Corporate Summary
  7.3.2 Zydus Cadila Business Overview
  7.3.3 Zydus Cadila Covid-19 Vaccine Major Product Offerings
  7.3.4 Zydus Cadila Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.3.5 Zydus Cadila Key News
7.4 Codagenix, Inc.
  7.4.1 Codagenix, Inc. Corporate Summary
  7.4.2 Codagenix, Inc. Business Overview
  7.4.3 Codagenix, Inc. Covid-19 Vaccine Major Product Offerings
  7.4.4 Codagenix, Inc. Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.4.5 Codagenix, Inc. Key News
7.5 GeoVax, Inc.
  7.5.1 GeoVax, Inc. Corporate Summary
  7.5.2 GeoVax, Inc. Business Overview
  7.5.3 GeoVax, Inc. Covid-19 Vaccine Major Product Offerings
  7.5.4 GeoVax, Inc. Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.5.5 GeoVax, Inc. Key News
7.6 Bravovax
  7.6.1 Bravovax Corporate Summary
  7.6.2 Bravovax Business Overview
  7.6.3 Bravovax Covid-19 Vaccine Major Product Offerings
  7.6.4 Bravovax Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.6.5 Bravovax Key News
7.7 Janssen Pharmaceutical Companies
  7.7.1 Janssen Pharmaceutical Companies Corporate Summary
  7.7.2 Janssen Pharmaceutical Companies Business Overview
  7.7.3 Janssen Pharmaceutical Companies Covid-19 Vaccine Major Product Offerings
  7.7.4 Janssen Pharmaceutical Companies Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.7.5 Janssen Pharmaceutical Companies Key News
7.8 Altimmune
  7.8.1 Altimmune Corporate Summary
  7.8.2 Altimmune Business Overview
  7.8.3 Altimmune Covid-19 Vaccine Major Product Offerings
  7.8.4 Altimmune Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.8.5 Altimmune Key News
7.9 Vaxart
  7.9.1 Vaxart Corporate Summary
  7.9.2 Vaxart Business Overview
  7.9.3 Vaxart Covid-19 Vaccine Major Product Offerings
  7.9.4 Vaxart Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.9.5 Vaxart Key News
7.10 CanSino Biologics
  7.10.1 CanSino Biologics Corporate Summary
  7.10.2 CanSino Biologics Business Overview
  7.10.3 CanSino Biologics Covid-19 Vaccine Major Product Offerings
  7.10.4 CanSino Biologics Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.10.5 CanSino Biologics Key News
7.11 ExpreS2ion Biotechnologies ApS
  7.11.1 ExpreS2ion Biotechnologies ApS Corporate Summary
  7.11.2 ExpreS2ion Biotechnologies ApS Business Overview
  7.11.3 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Major Product Offerings
  7.11.4 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.11.5 ExpreS2ion Biotechnologies ApS Key News
7.12 Clover Biopharmaceuticals
  7.12.1 Clover Biopharmaceuticals Corporate Summary
  7.12.2 Clover Biopharmaceuticals Business Overview
  7.12.3 Clover Biopharmaceuticals Covid-19 Vaccine Major Product Offerings
  7.12.4 Clover Biopharmaceuticals Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.12.5 Clover Biopharmaceuticals Key News
7.13 GSK
  7.13.1 GSK Corporate Summary
  7.13.2 GSK Business Overview
  7.13.3 GSK Covid-19 Vaccine Major Product Offerings
  7.13.4 GSK Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.13.5 GSK Key News
7.14 Vaxil Bio Ltd.
  7.14.1 Vaxil Bio Ltd. Corporate Summary
  7.14.2 Vaxil Bio Ltd. Business Overview
  7.14.3 Vaxil Bio Ltd. Covid-19 Vaccine Major Product Offerings
  7.14.4 Vaxil Bio Ltd. Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.14.5 Vaxil Bio Ltd. Key News
7.15 Generex
  7.15.1 Generex Corporate Summary
  7.15.2 Generex Business Overview
  7.15.3 Generex Covid-19 Vaccine Major Product Offerings
  7.15.4 Generex Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.15.5 Generex Key News
7.16 Novavax, Inc.
  7.16.1 Novavax, Inc. Corporate Summary
  7.16.2 Novavax, Inc. Business Overview
  7.16.3 Novavax, Inc. Covid-19 Vaccine Major Product Offerings
  7.16.4 Novavax, Inc. Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.16.5 Novavax, Inc. Key News
7.17 Sanofi Pasteur
  7.17.1 Sanofi Pasteur Corporate Summary
  7.17.2 Sanofi Pasteur Business Overview
  7.17.3 Sanofi Pasteur Covid-19 Vaccine Major Product Offerings
  7.17.4 Sanofi Pasteur Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.17.5 Sanofi Pasteur Key News
7.18 Baylor
  7.18.1 Baylor Corporate Summary
  7.18.2 Baylor Business Overview
  7.18.3 Baylor Covid-19 Vaccine Major Product Offerings
  7.18.4 Baylor Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.18.5 Baylor Key News
7.19 iBio, Inc.
  7.19.1 iBio, Inc. Corporate Summary
  7.19.2 iBio, Inc. Business Overview
  7.19.3 iBio, Inc. Covid-19 Vaccine Major Product Offerings
  7.19.4 iBio, Inc. Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.19.5 iBio, Inc. Key News
7.20 Zydus Cadila
  7.20.1 Zydus Cadila Corporate Summary
  7.20.2 Zydus Cadila Business Overview
  7.20.3 Zydus Cadila Covid-19 Vaccine Major Product Offerings
  7.20.4 Zydus Cadila Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.20.5 Zydus Cadila Key News
7.21 Moderna, Inc.
  7.21.1 Moderna, Inc. Corporate Summary
  7.21.2 Moderna, Inc. Business Overview
  7.21.3 Moderna, Inc. Covid-19 Vaccine Major Product Offerings
  7.21.4 Moderna, Inc. Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.21.5 Moderna, Inc. Key News
7.22 Curevac
  7.22.1 Curevac Corporate Summary
  7.22.2 Curevac Business Overview
  7.22.3 Curevac Covid-19 Vaccine Major Product Offerings
  7.22.4 Curevac Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.22.5 Curevac Key News
7.23 ImmunoPrecise
  7.23.1 ImmunoPrecise Corporate Summary
  7.23.2 ImmunoPrecise Business Overview
  7.23.3 ImmunoPrecise Covid-19 Vaccine Major Product Offerings
  7.23.4 ImmunoPrecise Covid-19 Vaccine Revenue in Global Market (2017-2022)
  7.23.5 ImmunoPrecise Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Covid-19 Vaccine Market Opportunities & Trends in Global Market
Table 2. Covid-19 Vaccine Market Drivers in Global Market
Table 3. Covid-19 Vaccine Market Restraints in Global Market
Table 4. Key Players of Covid-19 Vaccine in Global Market
Table 5. Top Covid-19 Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Covid-19 Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Covid-19 Vaccine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Covid-19 Vaccine Product Type
Table 9. List of Global Tier 1 Covid-19 Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Covid-19 Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Covid-19 Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Covid-19 Vaccine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Covid-19 Vaccine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Covid-19 Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Covid-19 Vaccine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Covid-19 Vaccine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Covid-19 Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Covid-19 Vaccine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Covid-19 Vaccine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Covid-19 Vaccine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Covid-19 Vaccine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Covid-19 Vaccine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Covid-19 Vaccine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Covid-19 Vaccine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Covid-19 Vaccine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Covid-19 Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Covid-19 Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Covid-19 Vaccine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Covid-19 Vaccine Revenue, (US$, Mn), 2023-2028
Table 30. Inovio Pharmaceuticals Corporate Summary
Table 31. Inovio Pharmaceuticals Covid-19 Vaccine Product Offerings
Table 32. Inovio Pharmaceuticals Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 33. Takis Biotech (Evvivax) Corporate Summary
Table 34. Takis Biotech (Evvivax) Covid-19 Vaccine Product Offerings
Table 35. Takis Biotech (Evvivax) Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 36. Zydus Cadila Corporate Summary
Table 37. Zydus Cadila Covid-19 Vaccine Product Offerings
Table 38. Zydus Cadila Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 39. Codagenix, Inc. Corporate Summary
Table 40. Codagenix, Inc. Covid-19 Vaccine Product Offerings
Table 41. Codagenix, Inc. Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 42. GeoVax, Inc. Corporate Summary
Table 43. GeoVax, Inc. Covid-19 Vaccine Product Offerings
Table 44. GeoVax, Inc. Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 45. Bravovax Corporate Summary
Table 46. Bravovax Covid-19 Vaccine Product Offerings
Table 47. Bravovax Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 48. Janssen Pharmaceutical Companies Corporate Summary
Table 49. Janssen Pharmaceutical Companies Covid-19 Vaccine Product Offerings
Table 50. Janssen Pharmaceutical Companies Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 51. Altimmune Corporate Summary
Table 52. Altimmune Covid-19 Vaccine Product Offerings
Table 53. Altimmune Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 54. Vaxart Corporate Summary
Table 55. Vaxart Covid-19 Vaccine Product Offerings
Table 56. Vaxart Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 57. CanSino Biologics Corporate Summary
Table 58. CanSino Biologics Covid-19 Vaccine Product Offerings
Table 59. CanSino Biologics Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 60. ExpreS2ion Biotechnologies ApS Corporate Summary
Table 61. ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Product Offerings
Table 62. ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 63. Clover Biopharmaceuticals Corporate Summary
Table 64. Clover Biopharmaceuticals Covid-19 Vaccine Product Offerings
Table 65. Clover Biopharmaceuticals Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 66. GSK Corporate Summary
Table 67. GSK Covid-19 Vaccine Product Offerings
Table 68. GSK Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 69. Vaxil Bio Ltd. Corporate Summary
Table 70. Vaxil Bio Ltd. Covid-19 Vaccine Product Offerings
Table 71. Vaxil Bio Ltd. Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 72. Generex Corporate Summary
Table 73. Generex Covid-19 Vaccine Product Offerings
Table 74. Generex Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 75. Novavax, Inc. Corporate Summary
Table 76. Novavax, Inc. Covid-19 Vaccine Product Offerings
Table 77. Novavax, Inc. Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 78. Sanofi Pasteur Corporate Summary
Table 79. Sanofi Pasteur Covid-19 Vaccine Product Offerings
Table 80. Sanofi Pasteur Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 81. Baylor Corporate Summary
Table 82. Baylor Covid-19 Vaccine Product Offerings
Table 83. Baylor Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 84. iBio, Inc. Corporate Summary
Table 85. iBio, Inc. Covid-19 Vaccine Product Offerings
Table 86. iBio, Inc. Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 87. Zydus Cadila Corporate Summary
Table 88. Zydus Cadila Covid-19 Vaccine Product Offerings
Table 89. Zydus Cadila Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 90. Moderna, Inc. Corporate Summary
Table 91. Moderna, Inc. Covid-19 Vaccine Product Offerings
Table 92. Moderna, Inc. Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 93. Curevac Corporate Summary
Table 94. Curevac Covid-19 Vaccine Product Offerings
Table 95. Curevac Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)
Table 96. ImmunoPrecise Corporate Summary
Table 97. ImmunoPrecise Covid-19 Vaccine Product Offerings
Table 98. ImmunoPrecise Covid-19 Vaccine Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Covid-19 Vaccine Segment by Type in 2021
Figure 2. Covid-19 Vaccine Segment by Application in 2021
Figure 3. Global Covid-19 Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Covid-19 Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Covid-19 Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Covid-19 Vaccine Revenue in 2021
Figure 8. By Type - Global Covid-19 Vaccine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Covid-19 Vaccine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Covid-19 Vaccine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Covid-19 Vaccine Revenue Market Share, 2017-2028
Figure 12. US Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Covid-19 Vaccine Revenue Market Share, 2017-2028
Figure 16. Germany Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 17. France Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Covid-19 Vaccine Revenue Market Share, 2017-2028
Figure 24. China Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. India Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Covid-19 Vaccine Revenue Market Share, 2017-2028
Figure 30. Brazil Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Covid-19 Vaccine Revenue Market Share, 2017-2028
Figure 33. Turkey Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Covid-19 Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. Inovio Pharmaceuticals Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Takis Biotech (Evvivax) Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Zydus Cadila Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Codagenix, Inc. Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GeoVax, Inc. Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bravovax Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Janssen Pharmaceutical Companies Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Altimmune Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Vaxart Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CanSino Biologics Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Clover Biopharmaceuticals Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. GSK Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Vaxil Bio Ltd. Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Generex Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Novavax, Inc. Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Sanofi Pasteur Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Baylor Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. iBio, Inc. Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Zydus Cadila Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Moderna, Inc. Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Curevac Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. ImmunoPrecise Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)